Kronos Bio, Inc.

Ownership Transactions Reported by 20 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	1	+3.62M	99.1%	$1.06	+$3.85M
Sells	3	-31.5K	0.9%	$1.05	-$33.2K
Net	-2	+3.59M	98.3%		+$3.82M

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Norbert W. Bischofberger	PRESIDENT & CEO, Director	$13.5M	+$3.85M	+40.1%	Jun 27, 2024
Barbara Kosacz	COO & General Counsel	$1.1M			Jan 4, 2024
Yasir B. Al-Wakeel	Chief Financial Officer	$410K			Jul 6, 2023
Jorge DiMartino	Chief Medical Officer & VP	$373K			Jan 4, 2024
Christopher Dinsmore	Chief Scientific Officer	$309K			Jan 4, 2024
Charles Y. Lin	Chief Scientific Officer	$247K	-$12.7K	-4.88%	Oct 15, 2024
Allison Frisbee	Chief Administrative Officer	$216K	-$12.8K	-5.59%	Oct 15, 2024
Elizabeth A. Olek	Sr Vp, Clinical Science	$204K	-$7.77K	-3.67%	Feb 21, 2024
Deborah Knobelman	Chief Financial Officer	$173K			Jun 3, 2024
Elena Ridloff	Director	$31.4K			Jun 25, 2024
Roshawn A. Blunt	Director				Jun 25, 2024
Arie Belldegrun	Director				Jun 25, 2024
Joshua A. Kazam	Director				Jun 25, 2024
Otello Stampacchia	Director				Jun 22, 2022
Taiyin Yang	Director				Jun 25, 2024
Sandra A. Gardiner	Interim CFO				Sep 15, 2023
Katherine V. Stultz	Director				Jun 25, 2024
David M. Tanen	Director				Jun 25, 2024
Marianne De Backer	Director				Jun 22, 2023
Roger D. Dansey	Director				Jun 25, 2024

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.